Aadi Bioscience, Inc.
AADINASDAQHealthcare
$2.05
$-0.05(-2.38%)
Market Cap$94891630
P/E Ratio—
52W High$3.812
52W Low$1.21
Aadi Bioscience, Inc. (AADI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · AADI · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $7.14M | $25.98M | $24.35M | $15.22M | $1.12M |
| Cost of Revenue | $0.00M | $3.02M | $2.81M | $1.33M | $0.28M |
| Gross Profit | $0.00M | $22.96M | $21.55M | $13.88M | ($18.55M) |
| Gross Margin %(computed) | 0.00% | 88.36% | 88.47% | 91.23% | — |
| Operating Expenses | |||||
| R&D Expenses | $90.96M | $51.03M | $48.93M | $32.66M | $19.67M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $18.51M |
| Total Operating Expenses | $121.55M | $90.42M | $93.48M | $72.84M | $92.67M |
| Operating Income | ($114.40M) | ($67.46M) | ($71.93M) | ($58.96M) | ($111.22M) |
| Operating Margin %(computed) | — | -259.62% | -295.36% | -387.47% | — |
| Interest Income | $6.23M | $3.92M | $6.40M | $2.40M | $0.01M |
| Interest Expense | $0.00M | $0.15M | $0.23M | $0.23M | $0.67M |
| Income Before Tax | ($20.60M) | ($63.69M) | ($65.77M) | ($60.51M) | ($110.09M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($20.60M) | ($63.69M) | ($65.77M) | ($60.51M) | ($110.09M) |
| Net Margin %(computed) | -288.26% | -245.13% | -270.04% | -397.69% | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.03 | $-2.36 | $-2.44 | $-2.69 | $-12.41 |
| Wtd Avg Shares | 618.87M | 26.99M | 26.92M | 22.51M | 8.92M |
| EBITDA | ($114.40M) | ($64.63M) | ($65.36M) | ($60.12M) | ($109.15M) |
| EBITDA Margin %(computed) | — | -248.72% | -268.40% | -395.14% | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more Aadi Bioscience, Inc. data
About Aadi Bioscience, Inc. (AADI) Income Statement
Aadi Bioscience, Inc. (AADI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, AADI reported revenue of $0.01B, gross profit of $0.00B (gross margin 0.00%), and net income of ($0.02B) — a net profit margin of -288.26%.
Frequently asked questions
AADI · 4 questionsAadi Bioscience, Inc. (AADI) reported revenue of $0.01B for 2025, down 72.5% year-over-year.
AADI revenueAADI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09